Affirma Biotech SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Affirma Biotech SL - overview
Established
2020
Location
Barcelona, -, Spain
Primary Industry
Biotechnology
About
Based in Barcelona, Spain, and founded in 2020, Affirma Biotech SL is a developer of advanced orally available immunotherapeutic drugs to combat severe infections and cancer. In February 2024, Affirma Biotech SL raised EUR 600,448 in venture funding led by investor Nara Capital, with participation from other investors, Genesis Biomed, Reig Jofre, and BCN Peptides. The funding was part of a larger EUR 1. 75 million equity and grant fund.
The company is managed by CEO Maribel Berges. The company offers orally bioavailable biochemical compounds that activate the immune system to address critical medical challenges such as antimicrobial resistance and the lack of broad-spectrum virus-targeting drugs. Affirma Biotech's therapeutic strategy stimulates the immune system by rejuvenating exhausted T-cells and offering broad-spectrum treatment options for various infectious diseases with significant unmet medical needs. Affirm severe influenza and infections, including cytomegalovirus, chronic hepatitis B, and resistant bacteria.
Current Investors
Reig Jofre, Agency for Business Competitiveness, ACCIÓ., Center for Technological & Industrial Development
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Biotechnology
Website
www.affirmabio.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Affirma Biotech SL - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|
| Revenue (USD) | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | (13,024.1) | - | - | - |
| Operating Income (USD) | (13,024.1) | - | - | - |
| Operating Margin | - | - | - | - |
| % EBITDA Margin | - | - | - | - |
| NET Income (USD) | (9,768.1) | - | - | - |
| % Net Margin | - | - | - | - |
Affirma Biotech SL - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.